stockportfolio.pro
Stocks / GMED vs RVTY
GMED vs RVTY
Globus Medical, Inc. and Revvity, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Globus Medical, Inc. (GMED) | Revvity, Inc. (RVTY) | |
|---|---|---|
| Market cap | $11.0B | $11.2B |
| Revenue (latest FY) | $2.94B | $2.86B |
| Net income (latest FY) | $537.87M | $241.20M |
| Revenue growth (5y CAGR) | 30.1% | -5.5% |
| Net margin | 18.3% | 8.4% |
| Return on equity | 11.8% | 3.3% |
| P/E ratio | 18.9 | 48.3 |
| Dividend yield | — | 0.3% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open GMED — free Open RVTY — freeFrequently asked questions
Which is bigger, GMED or RVTY?
Revvity, Inc. is larger by market capitalization — $11.2B versus $11.0B.
Which grows faster, GMED or RVTY?
Over the last five fiscal years, Globus Medical, Inc. grew revenue faster — 30.1%/yr versus -5.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.